• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

Oxford Biodynamics PLC (OBD)

ORD GBP0.001
Sell: 0.10p|Buy: 0.12p|Change: 0 (0%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment

This investment is listed on the Alternative Investment Market (AIM). Investments on this market can be higher risk and have lower liquidity, meaning they can be harder to buy or sell, and their prices may be more volatile. Before investing, make sure you understand the risks of investing.

Company profile

Oxford BioDynamics PLC is a biotechnology company focused on advancing personalized healthcare through the development and commercialization of precision medicine tests for serious and impactful diseases. The company is engaged in the commercialisation of proprietary molecular diagnostics products and biomarker research and development. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The company generates revenue from the sales of proprietary products and biomarker research and development. Geographically, it generates the maximum revenue from the USA.

Address

26 Beaumont Street
Oxford
GBR
OX1 2NP

Telephone

+44 1865518910

Website

https://www.oxfordbiodynamics.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Oxford BioDynamics PLC Second Quarter Earnings Results for 20272027-06-30T00:00:00
Oxford BioDynamics PLC Annual General Meeting for 20262027-01-26T10:00:00
Oxford BioDynamics PLC Annual Report for 20262026-12-22T00:00:00
Oxford BioDynamics PLC Fourth Quarter Earnings Results for 20262026-12-16T00:00:00

Previous key dates

NameKey Date
Oxford BioDynamics PLC Second Quarter Earnings Results for 20262026-06-30T00:00:00
Oxford BioDynamics PLC Annual General Meeting for 20252026-01-26T10:00:00
Oxford BioDynamics PLC Annual Report for 20252025-12-22T00:00:00
Oxford BioDynamics PLC Fourth Quarter Earnings Results for 20252025-12-16T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.